Minapharm Pharmaceuticals Acquires Majority Stake in ProBioGen
Dr. Wieland Wolf Appointed New CEO
ProBioGen AG announced that Minapharm Pharmaceuticals, Cairo, has completed the acquisition of 95% of the share capital of ProBioGen, an internationally renowned German cell line development and contract manufacturing specialist. The total purchase price of EUR 30.4 million includes earn-out payments which are conditional upon the achievement of defined milestones.
ProBioGen announced the appointment of Dr. Wieland Wolf as new CEO of the company who joined from Rentschler Biotechnologie GmbH, where he was a Member of the Management Board. Dr. Wolf is also President of the European Association of Pharma Biotechnology. He takes over responsibilities from Michael Schlenk, who joined the company in a Management Buy-In and who has successfully developed the company's business and worked towards the exit process.
Most read news
Organizations
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents
Protein closely linked to commonest cause of blindness
Hybrigenics’ inecalcitol gets Orphan Drug designation for the treatment of Acute Myeloid Leukemia in the United States
QIAGEN and Roche settle dispute over distribution agreement for TheraScreen companion diagnostics

Salt could be a key factor in allergic immune reactions - Atopic dermatitis: elevated salt concentrations in affected skin

Contact lenses with medicine and sugar
Deutsches Primatenzentrum GmbH (DPZ) - Göttingen, Germany
Creabilis Raises €15M in Series B Fundraising Round

A giant called MIMAS in the cell power plants - Mega protein complex with surprising properties discovered in mitochondria

Rapid detection of antibiotic-resistant bacteria
BIOTECON Diagnostics signs license agreement with Applera Corporation

News from the Mailroom of the Cell - Researchers elucidate mechanism of protein
